These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29402680)

  • 41. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized trial of methadone treatment of arrestees: 24-month post-release outcomes.
    Schwartz RP; Kelly SM; Mitchell SG; O'Grady KE; Duren T; Sharma A; Gryczynski J; Jaffe JH
    Drug Alcohol Depend; 2021 Jan; 218():108392. PubMed ID: 33187759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).
    Smith LR; Mittal ML; Wagner K; Copenhaver MM; Cunningham CO; Earnshaw VA
    Addiction; 2020 Feb; 115(2):354-367. PubMed ID: 31478272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
    Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
    Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
    Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
    Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.
    Bazazi AR; Culbert GJ; Wegman MP; Heimer R; Kamarulzaman A; Altice FL
    BMC Infect Dis; 2022 Nov; 22(1):837. PubMed ID: 36368939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing death among the recently incarcerated: an argument for naloxone prescription before release.
    Wakeman SE; Bowman SE; McKenzie M; Jeronimo A; Rich JD
    J Addict Dis; 2009; 28(2):124-9. PubMed ID: 19340674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergency department utilization by individuals with opioid use disorder who were recently incarcerated.
    Will J; Abare M; Olson M; Chyorny A; Wilhelm-Leen E
    J Subst Abuse Treat; 2022 Oct; 141():108838. PubMed ID: 35868162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.
    Banta-Green CJ; Williams JR; Sears JM; Floyd AS; Tsui JI; Hoeft TJ
    Drug Alcohol Depend; 2020 Feb; 207():107799. PubMed ID: 31865058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.
    Harris A; Selling D; Luther C; Hershberger J; Brittain J; Dickman S; Glick A; Lee JD
    Subst Abus; 2012; 33(1):70-5. PubMed ID: 22263715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova.
    Dorgay CE; Bromberg DJ; Doltu S; Litz T; Galvez S; Polonsky M; Dvoryak S; Altice FL
    Int J Drug Policy; 2022 Jun; 104():103683. PubMed ID: 35417790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism.
    McMillan GP; Lapham S; Lackey M
    Addiction; 2008 Dec; 103(12):2017-23. PubMed ID: 19469745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.
    Smith KE; Tillson MD; Staton M; Winston EM
    Drug Alcohol Depend; 2020 Mar; 208():107837. PubMed ID: 31951906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accessing opioid agonist treatment in prison in England and Scotland remains problematic - the views of people with lived experience.
    Webster R; Fearns C; Harriott P; Millar L; Simpson J; Wallace J; Wheatley M
    Int J Prison Health (2024); 2024 May; 20(2):143-155. PubMed ID: 38984599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors affecting the dose of methadone among patients receiving methadone maintenance therapy in Taiwan.
    Li DJ; Chung KS; Wu HC; Hsu CY; Yen CF
    Am J Addict; 2018 Apr; 27(3):225-230. PubMed ID: 29569392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of motor vehicle collisions after methadone use.
    Yang YH; Ho PS; Wu TN; Wang PW; Lin CR; Tsai JH; Guo YL; Chuang HY
    Elife; 2021 Aug; 10():. PubMed ID: 34351275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response.
    Dvoriak S; Karachevsky A; Chhatre S; Booth R; Metzger D; Schumacher J; Chychula N; Pecoraro A; Woody G
    Drug Alcohol Depend; 2014 Apr; 137():62-7. PubMed ID: 24548802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ; Brown S; Greenwald MK; Ledgerwood DM
    Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada.
    Klimas J; Nosova E; Socías E; Nolan S; Brar R; Hayashi K; Milloy MJ; Kerr T; Wood E
    Drug Alcohol Depend; 2018 May; 186():182-186. PubMed ID: 29604525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.